Who
David Parrot
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Scribe Therapeutics.
In numbers
- Trades disclosed
- 10
- Buys
- 1
- Sells
- 0
- Bought
- $80K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Mar 2026
- Last trade
- 23 Jul 2026
- Last filed
- 27 Jul 2026
Companies traded
Activity over time
1 Jul – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jul 2026filed 27 Jul 2026 | SCTX Scribe TherapeuticsBiotechnology | SEC FORM 4 Bought | $20K1,333 at $15.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | SCTX Scribe TherapeuticsBiotechnology | SEC FORM 4 Bought | $20K1,333 at $15.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | SCTX Scribe Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —109,426 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | SCTX Scribe Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —109,426 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | SCTX Scribe Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —109,426 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | SCTX Scribe Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —109,426 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | SCTX Scribe TherapeuticsBiotechnology | SEC FORM 4 Bought | $20K1,333 at $15.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | SCTX Scribe TherapeuticsBiotechnology | SEC FORM 4 Bought | $20K1,333 at $15.00 | filing |
| 13 Mar 2026filed 27 Jul 2026 | SCTX Scribe Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,909 at $0.00 | filing |
| 13 Mar 2026filed 27 Jul 2026 | SCTX Scribe Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,909 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.